High density lipoproteins and atherosclerosis III : proceedings of the 3rd International Symposium on Plasma High Density Lipoproteins and Atherosclerosis, San Antonio, 4-6 March 1992
著者
書誌事項
High density lipoproteins and atherosclerosis III : proceedings of the 3rd International Symposium on Plasma High Density Lipoproteins and Atherosclerosis, San Antonio, 4-6 March 1992
(International congress series, no. 1001)
Excerpta Medica, 1992
大学図書館所蔵 全7件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
Plasma high density lipoproteins (HDL) concentration is now recognized as a major independent risk factor for coronary atherosclerosis. New information on HDL metabolism has emerged in recent years which sheds light on the mechanisms which underly this association. In particular the techniques of molecular genetics and experimental pathology are being combined to explore the roles of different HDL apolipoproteins, enzymes and lipid transfer proteins in the atherogenic process. This book summarizes the important developments which have taken place in this field since the last International Symposium on the subject was held in 1988, with contributions from leading researchers. It should be of interest to all those working in the fields of lipoproteins, lipid transport, hyperlipidaemia, atherosclerosis, vascular disease, cardiology, experimental pathology and molecular biology.
目次
High density lipoprotein gene regulation. Identification of genetic loci contributing to high density lipoprotein metabolism and early atherosclerosis in a mouse model (C.H. Warden et al). Genetics of the lipoprotein lipase/apolipoprotein C-II lipolytic system: Insight from structural and evolutionary considerations (L. Chan). Apolipoprotein AI gene regulation by members of the steroid/thyroid hormone receptor superfamily of ligand dependent transcription factors (S.K. Karathanasis). Genetic variation in mouse apolipoprotein A-IV expression (K. Reue et al). Enzymes affecting high density lipoproteins. Lipase structural domains involved in HDL generation and processing (R.C. Davis and H. Wong). Cholesteryl ester transfer protein (CETP) transgenic mice: Lipoprotein metabolism and regulation of CETP gene expression (A.R. Tallet al). Molecular defects in the lecithin: Cholesterol acyltranserase gene (J.W. McLean). Regulation of the reaction of high density lipoproteins with lecithin: Cholesterol acyltransferase (A. Jonas, D.J. Bolin and F.S. Bonelli). High density lipoprotein structure. Modulation of HDL precursor structure and metabolism (A.V. Nichols, E.L. Gong and A.R. Tall). Apolipoprotein A-IV and high density lipoproteins: A tenuous interaction (R.B. Weinberg). Apolipoprotein A-I: Structure, lipid interaction and activation of lecithin: Cholesterol acyltransferase (Y.L. Marcel et al). Contribution of helix-helix interactions to the stability of apolipoprotein-lipid complexes (M. Rosseneu et al). High density lipoprotein-cell interactions. Cholesterol transport between cells and high density lipoproteins (M.C. Phillips et al). HDL receptor-mediated transport of cholesterol from cells (J.F. Oram et al). ApoA-containing lipoprotein particles: Interactions with HDL binding sites and reverse cholesterol transport (J.-C. Fruchart, G. Ailhaud and P. Denefle). High density lipoprotein-cell interactions (C.J. Fielding et al). Animal models of HDL metabolism and atherosclerosis. HDL metabolism: Studies in transgenic mice (J.L. Breslow). High density lipoprotein subpopulation distribution (S. Eisenberg). Lipoproteins and atherosclerosis in transgenic mice expressing HDL associated apolipoproteins (E. Rubin). Reverse cholesterol transport and physiology. Apolipoprotein E: Structure-function correlations (K.H. Weisgraber, S. Lund-Katz and M.C. Phillips). Mice lacking apolipoprotein A-I and tissues regulated by lipolysis of triglyceride-rich lipoproteins? (N.E. Miller). Interstitial fluid lipoprotein metabolism (P.S. Roheim et al). Human HDL metabolism and genetics. Determinants of HDL metabolism in subjects with low HDL-C levels (E.A. Brinton, S. Eisenberg and J.L. Breslow). Role of the kidney in increased clearance of apolipoprotein A-I in subjects with reduced high density lipoprotein cholesterol concentrations (B.S. Horowitz et al). Drugs, hormones and epidemiology.
「Nielsen BookData」 より